Advertisement
Advertisement
KYMR
Kymera Therapeutics, Inc. Common Stock
112.40
USDSponsored
+3.10
+2.84%
Oct 09, 16:00 UTC -4
Closed
After-Market
112.06
-0.34
-0.30%
Kymera Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 9.32B |
| Beta | 1.98 |
| Earnings Per Share (EPS) | -3.24 |
| Price-to-Book (P/B) Ratio | 5.91 |
| Operating Margin | -281.66% |
| Total Debt/Equity (D/E) | 0.16% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -21.22% |
| Current Ratio | 10.34% |
| Free Cash Flow | -143.81M |
